MedTrace Logo

Screening of Serum Exosomal miRNA as a Biomarker for Ocular Muscle Myasthenia Gravis

NCT05888558 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 160

Last updated 2023-06-05

No results posted yet for this study

Summary

Ocular muscle myasthenia gravis (Ocular Myasthenia Gravis, OMG) has a high incidence and is difficult to diagnose. It is very necessary to find specific diagnostic indicators for OMG. By collecting peripheral blood of OMG, systemic myasthenia gravis and healthy people, extract miRNAs derived from exosomes in the serum and perform high-throughput sequencing, then use bioinformatics analysis methods to screen specifically expressed miRNAs as biomarkers for OMG diagnosis .

Conditions

Interventions

DEVICE

Body fluid diagnosis

miRNAs derived from exosomes in the serum

Sponsors & Collaborators

  • First Affiliated Hospital of Jinan University

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-07-04
Primary Completion
2024-03-31
Completion
2024-05-31

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05888558 on ClinicalTrials.gov